glp-1 receptor agonists and cancer risk in adults with obesity NEW: A systematic review found that #GLP1 have little or no effect on the for obesity-related cancers. The findings offer insights into the safety of GLP-1RAs suggest no Patients taking GLP-1 receptor agonists
Description
Oral administration is the fastest-growing route, because the traditional delivery method has shown therapeutic benefits
First submitted to a journal in 1989, the article was finally published in 1992
Our New You 14-Day Weight Loss Challenge is designed to help you burn fat, improve metabolism, and feel stronger from the inside out
GLP-1 analogue, exendin-4, modulates MAPKs activity but not the heat shock response in human HepG2 cells
doi: 10.1007/s001250050779 61 KubotaAYamadaYHayamiTYasudaKSomeyaYIharaYet al
Historically, anti-obesity drugs have shown a lot of negative side effects and only moderate efficacy
